Alembic Pharma Ltd on Wednesday, 11 December, announced that it had successfully completed the API-II facility audit at Panelav for eight active pharmaceutical ingredients (APIs)...
Aurobindo Pharma Limited shares were 2% lower after the company informed over its regulatory filing that its subsidiary APL Healthcare Limited got the World Health...
The US Food and Drug Administration (FDA) has suspended a Phase 2/3 clinical trial of Bharat Biotech’s COVID-19 vaccine Covaxin in the US According to...